SABBY MANAGEMENT, LLC

Q2 2017 13F Holdings Report, Restatement, Stock Holdings

Signature - Title: Robert Grundstein - Chief Operating Officer
Location: Miami Beach, FL
Holdings as of: 30 Jun 2017
Value $: $218,004,000
Num holdings: 112
Filing time: 27 Sep 2017, 11:49:36 UTC
Form type: 13F-HR/A-1 - Restatement
Description: All US holdings of this investor are reported in this report. Top holdings included BRISTOL MYERS SQUIBB, TSRO, UTHR, SGEN, and BIOAQ.
Previous filing: Q1 2017 - 16 May 2017
Next filing: Q3 2017 - 14 Nov 2017
SEC: View on sec.gov
Options Holdings: Showing stock holdings, see here for options holdings

Sym	Weight	Trade Impact	Company	Class	Share Change	Activity	Value Change $	Value $	* Price $	Shares	Principal

Filing 2017 Q2 - Restatement compared to 2017 Q1 - Restatement by default. Changes are calculated vs the previous SEC filing.

Compare Q2 2017 to

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name	Title	City, State	Date
Robert Grundstein	Chief Operating Officer	Upper Saddle River, New Jersey	27 Sep 2017

This amendment is being filed to properly reflect our holdings in InspireMD, Inc., which included 22,704 shares and two series of warrants exercisable into 1,209,425 and 2,002,348 shares, respectively. We inadvertently included the warrants as shares in our previous filing.

Other Included Managers (1):

Num	Name	Location	File Number
1	Mintz Hal		028-13502